InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Abbott Laboratories

ABT Clue Score62
United States Fiscal year ends December CIK 0000001800 Results filed 21 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
John F Ginascol
27 Oct 2021
Executive Vice President
Exercised, kept
45,709
$47.00
$2.15M
William A Osborn
26 Oct 2021
Director
Exercised, kept
15,752
$59.42
$935.98K
Jr. Robert E. Funck,
2 Feb 2021
Executive Vice President
Exercised, kept
31,325
$39.12
$1.23M
William A Osborn
24 Nov 2020
Director
Exercised, kept
21,448
$43.64
$935.99K
John F Ginascol
1 Sep 2020
Executive Vice President
Exercised, kept
39,953
$44.40
$1.77M
John F Ginascol
1 Sep 2020
Executive Vice President
Exercised, kept
20,133
$38.40
$773.11K
John F Ginascol
1 Sep 2020
Executive Vice President
Exercised, kept
12,012
$47.00
$564.56K
Jaime Contreras
21 Apr 2020
Senior Vice President
Exercised, kept
25,681
$75.90
$1.95M
Jaime Contreras
21 Apr 2020
Senior Vice President
Exercised, kept
36,715
$59.94
$2.20M
Jaime Contreras
21 Apr 2020
Senior Vice President
Exercised, kept
46,016
$44.40
$2.04M
Jr. Robert E. Funck,
21 Apr 2020
Executive Vice President & CFO
Exercised, kept
13,000
$39.12
$508.56K
Jr. Robert E. Funck,
21 Apr 2020
Executive Vice President & CFO
Exercised, kept
23,700
$34.94
$828.08K
Jr. Robert E. Funck,
9 Aug 2019
Senior Vice President
Exercised, kept
40,000
$34.94
$1.40M
Jaime Contreras
26 Apr 2019
Senior Vice President
Exercised, kept
80,860
$38.40
$3.11M
Showing 250 of 1,360 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 916
Amendments (4/A) skipped 6
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 384
Sales at will 719
Transactions with no price 0
Shares from compensation/vesting 17,573,242
Sales filed before the plan box existed 692
History held since 3 Oct 2006